Khorana Score
Predicts venous thromboembolism (VTE) risk in ambulatory cancer patients starting chemotherapy from five items (tumor site, platelets, hemoglobin/ESA use, WBC, BMI); not for inpatients or those already on therapeutic anticoagulation.
Predicts venous thromboembolism (VTE) risk in ambulatory cancer patients starting chemotherapy from five items (tumor site, platelets, hemoglobin/ESA use, WBC, BMI); not for inpatients or those already on therapeutic anticoagulation.